Divi's Laboratories Limited Share Price and Company Fundamentals
Last traded: Today at 9:45 AM
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Key Metrics
PE ratio
88.21
PB ratio
13.56
Dividend yield
0.35%
Beta
0.22
Market cap
₹2272.41B
Enterprise value
₹2240.15B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 11565 |
| Website | https://www.divislabs.com |
| Mailing address | Divi Towers 1-72/23(P)/DIVIS/303 Cyber Hills Gachibowli Hyderabad 500032 India |
| Phone / Fax | 91 40 6696 6300 / 91 40 6696 6460 |
Dividends
Dividend yield
0.35%
Dividend amount
₹30.00
Payout ratio
31.01%
5Y Avg. yield
-%
Divi's Laboratories Limited paid ₹30.00 dividend and the ex-dividend date was 24 Jul 2026.The dividend payout ratio is 31.01%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.DIVISLAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Aug 2026, following are the company executives and directors listed on Divi's Laboratories Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Kiran Satchandra Divi B. Pharm., M.Pharm | CEO & Whole-Time Director | 49 | |
| Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) | Executive Director | 67 | |
| Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. | MD & Executive Director | 74 | |
| Dr. Devendra Rao Sureddy M.Sc. | Whole-Time Director (Manufacturing) | 63 | |
| Ms. Nilima Prasad Divi | Whole-time Director, Chief Control Officer & Director of Commercial | 42 | |
| Mr. Venkatesa Perumallu Pasumarthy B.Com., F.C.A. | Chief Financial Officer | 64 | |
| Mr. Manoranjan Jasti | Chief Information Officer | ||
| Mr. Meka Satish Choudhury | Company Secretary & Compliance Officer | ||
| Mr. Satya Prakash Divi B.Tech (Mech), MBA, MS (CIS) | Vice President of Sales, Marketing & Logistics | 48 | |
| Mr. Y. T. S. Prasad B.E. | Global Quality Head | 56 |
Profitability and management effectiveness
Profit margin
26.05%
Operating margin
36.66%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Divi's Laboratories Limited is 2272.41B and its enterprise value is 2240.15B. The enterprise value to revenue ratio of DIVISLAB is 19.95. The enterprise value to EBITDA ratio of DIVISLAB is 56.49.
The DIVISLAB's stocks Beta value is 0.22 making it 78% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Divi's Laboratories Limited (NSE:DIVISLAB) Frequently Asked Questions
1. What is Divi's Laboratories Limited's Stock Symbol?
Divi's Laboratories Limited trades on NSE under the ticker symbol "DIVISLAB".
2. What is Divi's Laboratories Limited's stock price today?
One share of DIVISLAB stock can currently be purchased for approximately ₹8560.
3. How can I contact Divi's Laboratories Limited?
Divi's Laboratories Limited's mailing address is Divi Towers 1-72/23(P)/DIVIS/303 Cyber Hills Gachibowli Hyderabad 500032 India. The company can be reached via phone at 91 40 6696 6300.
4. What is Divi's Laboratories Limited's official website?
The official website of Divi's Laboratories Limited is https://www.divislabs.com.